Sugi Predict

Sugi Predict / Compounds / SCHEMBL335511

SCHEMBL335511

SCHEMBL335511

O=C/C=C/c1ccccc1Br

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK4 P11802 3/20 0.57
▸ CCND1 P24385 3/20 0.57
▸ HSD11B1 P28845 3/20 0.55
▸ LMNA P02545 2/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ TRPA1 O75762 1/20 0.48
▸ ALOX5 P09917 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ LY96 Q9Y6Y9 1/20 0.46
▸ CCNB2 O95067 1/20 0.46
▸ CDK1 P06493 1/20 0.46
▸ CCNB1 P14635 1/20 0.46
▸ CCNB3 Q8WWL7 1/20 0.46
▸ BCHE P06276 1/20 0.43
▸ KMT2A Q03164 4/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ THRB P10828 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ IKBKB O14920 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29956738 1.00 CDK4 (0.57) CDK4CCND1HSD11B1LMNAALDH1A1
SCHEMBL1307554 1.00 CDK4 (0.57) CDK4CCND1HSD11B1LMNAALDH1A1
SCHEMBL28278440 1.00 CDK4 (0.57) CDK4CCND1HSD11B1LMNAALDH1A1
SCHEMBL11070320 0.83 CDK4 (0.70) CDK4CCND1LMNAALDH1A1TRPA1
SCHEMBL16476616 0.83 CDK4 (0.70) CDK4CCND1LMNAALDH1A1TRPA1
SCHEMBL12712651 0.83 HSD11B1 (0.52) CDK4CCND1HSD11B1LMNALY96
SCHEMBL11813801 0.83 CDK4 (0.48) CDK4CCND1HSD11B1LMNAALDH1A1
SCHEMBL1751871 0.80 HSD11B1 (0.62) HSD11B1LMNAALDH1A1MAPK1LY96
SCHEMBL297691 0.80 HSD11B1 (0.62) HSD11B1LMNAALDH1A1MAPK1LY96
SCHEMBL31613215 0.80 HSD11B1 (0.62) HSD11B1LMNAALDH1A1MAPK1LY96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122010897-A Naphthiophene compound, preparation method and application 新疆大学 2026-05-12 — — CN claimed
CN-221587294-U Feeding device for producing alpha-bromocinnamaldehyde 郓城诚源医药科技有限公司 2024-08-23 — — CN claimed
CN-221358620-U Alpha-bromocinnamaldehyde draws equipment 郓城诚源医药科技有限公司 2024-07-19 — — CN claimed
CN-221267133-U Alpha-bromocinnamaldehyde draws evaporation equipment 郓城诚源医药科技有限公司 2024-07-05 — — CN claimed
CN-115645379-A Alpha-bromo-cinnamaldehyde nanosheet antibacterial agent and preparation method thereof 西安建筑科技大学 2023-01-31 — — CN claimed
CN-113178602-A Preparation of ZIF-8/polyether-ether-ketone and ZIF-8@ GO/polyether-ether-ketone anion composite membrane 长春工业大学 2021-07-27 — — CN claimed
CN-110629565-A After-finishing process of rayon yarn 徐州锦业纺织科技有限公司 2019-12-31 — — CN claimed
EP-3201290-A1 SYNTHETIC ACID COMPOSITIONS ALTERNATIVES TO CONVENTIONAL ACIDS IN THE OIL AND GAS INDUSTRY Fluid Energy Group Ltd (CA) 2017-08-09 — — EP claimed
WO-2016190865-A1 CORROSION INHIBITION OF HCL TREATMENT FLUIDS WITH ENVIRONMENTALLY COMPATIBLE SOLVENT HALLIBURTON ENERGY SERVICES, INC. (US) 2016-12-01 — — WO claimed
WO-2016049744-A1 SYNTHETIC ACID COMPOSITIONS ALTERNATIVES TO CONVENTIONAL ACIDS IN THE OIL AND GAS INDUSTRY FLUID ENERGY GROUP LTD. (CA) 2016-04-07 — — WO claimed
CN-103864731-B Containing the synthetic method of the furans lactonic ring compounds of quaternary carbon chiral centre CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE (CN) 2016-01-20 — — CN claimed
US-20150038471-A1 PROCESS FOR PREVENTING OR MITIGATING BIOFOULING BAKER HUGHES INCORPORATED (US) 2015-02-05 — — US claimed
CN-103864731-A Synthetic method of furan lactonic ring compound containing quaternary carbon chiral center UNIV CHENGDU TRAD CN MEDICINE 2014-06-18 — — CN claimed
EP-2419549-A1 CORROSION INHIBITOR COMPOSITIONS COMPRISING THE REACTION PRODUCT FORMED FROM AN ALDEHYDE WITH A THIOL AND/OR AN AMINE FUNCTIONALIZED RING STRUCTURE AND ASSOCIATED METHODS Halliburton Energy Services, Inc. (US) 2012-02-22 — — EP claimed
WO-2011100189-A2 PROCESS FOR PREVENTING OR MITIGATING BIOFOULING BAKER HUGHES INCORPORATED (US) 2011-08-18 — — WO claimed
US-20110195938-A1 PROCESS FOR PREVENTING OR MITIGATING BIOFOULING BAKER HUGHES INCORPORATED (US) 2011-08-11 — — US claimed
WO-2010119235-A1 CORROSION INHIBITOR COMPOSITIONS COMPRISING THE REACTION PRODUCT FORMED FROM AN ALDEHYDE WITH A THIOL AND/OR AN AMINE FUNCTIONALIZED RING STRUCTURE AND ASSOCIATED METHODS HALLIBURTON ENERGY SERVICES, INC. (US) 2010-10-21 — — WO claimed
EP-2125989-A1 IMPROVED CORROSION-INHIBITING ADDITIVES, TREATMENT FLUIDS, AND ASSOCIATED METHODS Halliburton Energy Services, Inc. (US) 2009-12-02 — — EP claimed
WO-2008110789-A1 IMPROVED CORROSION-INHIBITING ADDITIVES, TREATMENT FLUIDS, AND ASSOCIATED METHODS HALLIBURTON ENERGY SERVICES, INC. (US) 2008-09-18 — — WO claimed
WO-2008071928-A2 CORROSION INHIBITOR INTENSIFIER COMPOSITIONS AND ASSOCIATED METHODS HALLIBURTON ENERGY SERVICES, INC. (US) 2008-06-19 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150038471-A1 PROCESS FOR PREVENTING OR MITIGATING BIOFOULING ADH1A, ADH1C, FUCA2 CDK4 3812/4885CCND1 2467/4885HSD11B1 856/4885
US-20110195938-A1 PROCESS FOR PREVENTING OR MITIGATING BIOFOULING ADH1A, CHIT1, ADH1C CDK4 4014/4885CCND1 2366/4885HSD11B1 456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.